Related Experiment Video
Updated: Mar 3, 2026

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
Published on: July 11, 2025
The relationship between amniotic fluid miRNAs and congenital obstructive nephropathy
Juntao Xie1, Yi Zhou2, Wenzong Gao1
1Department of Pediatric Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityGuangdong, People's Republic of China.
Abstract:
Exosomes are small membrane vesicles with size of 30-100 nm, which were found in bodily fluids including amniotic fluid and saliva. The biological materials in exosomes, such as proteins and RNA, can be used as novel potential biomarkers for diagnostic assays. The purpose of this study was to assess whether exosomal microRNAs (miRNAs) could be used as biomarkers to prenatally diagnose congenital hydronephrosis and to evaluate fetal kidney function. Transmission electron microscopy (TEM), flow cytometry (FACS), and western-blot were applied to identify exosomes in the amniotic fluid from fetuses with congenital hydronephrosis and healthy controls. Exosomal miRNA was extracted according to the manufacturer's protocol and used for microarray. The differentially expressed miRNAs were selected for further study. The miRNA targets were analyzed to assess their possible function in the pathophysiology of obstructive nephropathy, and the miRNA array results were confirmed by qPCR. Amniotic fluid exosomes were identified based on CD24 and CD9 expression. The has-miR-942, has-miR-4289, has-miRPlus-A1073, and has-miR-195-3p were up-regulated in amniotic fluid exosomes from fetuses with congenital hydronephrosis comparing with those in healthy controls, and 35 had reduced expression levels. These results were confirmed by using qPCR. After integrating the miRNAs targets predicted via three databases and subjecting those target genes to KEGG pathway analysis, we found that the target genes of hsa-miR-300 and hsa-miR-299-5p were determined to be part of the Wnt signaling pathway. In addition, DVL2, PP2R5A, SRFP2, and SIAH1 predicted as target genes of has-miR-300 and has-miR-299-5p are informative for further exploration of congenital hydronephrosis pathologies. The reduced expression of hsa-miR-300 and hsa-miR-299-5p in the amniotic fluid of congenital hydronephrosis could be a biomarker for kidney fibrosis associated with congenital obstructive nephropathy.
Insights
Exosomal microRNAs (miRNAs) in amniotic fluid show promise as biomarkers for prenatal diagnosis of congenital hydronephrosis. Specific miRNAs, like hsa-miR-300 and hsa-miR-299-5p, may indicate kidney fibrosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Exosomes, small vesicles in bodily fluids, contain proteins and RNA.
- Exosomal contents, including microRNAs (miRNAs), are potential biomarkers for diagnostics.
Purpose of the Study:
- To investigate exosomal miRNAs in amniotic fluid as biomarkers for prenatal diagnosis of congenital hydronephrosis.
- To evaluate fetal kidney function using exosomal miRNA profiles.
Main Methods:
- Exosomes isolated from amniotic fluid of fetuses with and without congenital hydronephrosis.
- Transmission electron microscopy, flow cytometry, and western blot for exosome identification (CD24, CD9 expression).
- Microarray analysis of exosomal miRNA, followed by qPCR validation and bioinformatic target analysis (KEGG pathways).
Main Results:
- Four miRNAs (has-miR-942, has-miR-4289, has-miRPlus-A1073, has-miR-195-3p) were upregulated; 35 miRNAs were downregulated in congenital hydronephrosis cases.
- hsa-miR-300 and hsa-miR-299-5p target genes are involved in the Wnt signaling pathway.
- Specific target genes (DVL2, PP2R5A, SRFP2, SIAH1) identified for hsa-miR-300 and hsa-miR-299-5p.
Conclusions:
- Exosomal miRNAs in amniotic fluid can serve as potential biomarkers for prenatal diagnosis of congenital hydronephrosis.
- Reduced expression of hsa-miR-300 and hsa-miR-299-5p may indicate kidney fibrosis in congenital obstructive nephropathy.
Related Concept Videos
Nephrons
Nephrotic Syndrome I : Introduction
Teratogenicity
Acute Kidney Injury II: Pathophysiology

